We have received funding by means of sponsorship from multiple pharmaceutical companies and MedTech industries to support the delivery of our national conference.
The sponsoring companies are Abbott, Lilly, Roche Diagnostics, Ascensia, Medtrum, Nipro and Novo Nordisk.
Our sponsors have had no editorial input or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.
Abbott is a global healthcare leader that helps people live life to the full. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.
At Abbott, we believe people with diabetes should enjoy active lives, so we’re focused on making breakthrough technology accessible and approachable for all. Our groundbreaking sensing technology is revolutionising how people monitor their glucose and provides healthcare professionals with more data to make more informed treatment decisions.
© 2026 Abbott. ADC-129168 03/26 v1.0
Website: Home | Healthcare Professionals | FreeStyle | Abbott
Lilly is a medicine company turning science into therapies to make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are advancing new discoveries to address some of the world’s most significant health challenges.
We have been a global leader in diabetes since 1923, and are redefining diabetes and obesity care today. Through research, medicines, technologies, support programs and more, we strive to make life better for people living with diabetes and obesity.
To learn more, visit www.lilly.com/uk or www.linkedin.com/showcase/eli-lilly-and-company-uk-and-ireland/.
With nearly 50 years of experience, Roche is dedicated to helping people with diabetes think less about their daily routines so they can experience true relief, day and night. Through our Accu-Chek® and mySugr® brands, we offer an integrated ecosystem of solutions, from traditional blood glucose monitoring to predictive continuous glucose monitoring (CGM) technology and digital data management, supporting people with diabetes and healthcare providers, no matter where they are on their diabetes journey.
Learn more: accu-chek.co.uk/hcp
Ascensia Diabetes Care is committed to empowering people with diabetes by delivering smart, innovative solutions that simplify daily management and enhance quality of life.
The CONTOUR®PLUS BLUE meter and strips offer high accuracy and feature Second‑Chance® sampling, allowing users to add more blood to the same strip within 30 seconds. This helps reduce wasted strips and minimises frustration. The smartCOLOUR™ target range indicator provides clear, easy‑to‑understand feedback to support confident self‑monitoring.
As a trusted partner in the diabetes community, we work closely with healthcare professionals to ensure our products meet the highest standards of accuracy, precision, and reliability.
Learn more here: https://www.diabetes.ascensia.co.uk/
Empowered by 100 years of innovation, our mission at embecta is to develop and provide solutions that make life better for people living with diabetes. embecta is a leading producer of diabetes injection devices, manufacturing approximately 8 billion devices annually for an estimated 30 million PWD. Through its approximately 2,000 employees around the world, embecta is working to advance the standard of care in insulin delivery through strong community partnerships, innovative technology and comprehensive care resources.
About embecta™ – Discover Our Mission & History
Medtrum is a global medical technology company dedicated to simplifying diabetes management through smart and simple patient-centred innovation.
Our TouchCare® Nano Hybrid Closed-Loop Automated Insulin Delivery (AID) System integrates the TouchCare® Nano Patch Pump, TouchCare® Nano Continuous Glucose Monitoring (CGM) and offers flexible control via the EasyPatch App on (iOS and Android) or a dedicated Personal Diabetes Manager (PDM).
The TouchCare® Nano Patch Pump is tubeless, waterproof1, discreet2 and designed for up to 3 days of continuous insulin delivery.
Medtrum’s HCL function known as AutoMode is controlled by the APGO algorithm which delivers automated insulin therapy that adapts to glucose trends to help support improved Time in Range.
Medtrum is committed to delivering clinically effective and accessible diabetes technologies across the UK and Europe. Medtrum pumps and CGM are widely available via the NHS in the UK and across Europe. For more information, visit www.medtrum.co.uk.
1IP28 rating depth of 2.5 meters for 1 hour
2Specification: 40.5mm x 31.5mm 11.5mm, 13.8g
Nipro is a leading global healthcare company, established in 1954 with over 38,000 employees worldwide.
Nipro is committed to simplifying diabetes management with easy-to-use products combining 99.33% accuracy along with Nipro’s leading Customer Service.
Our 4SURE portfolio includes a blood glucose meter, combined blood glucose and β-ketone meter, we also provide blood glucose and ketone test strips, a wide range of insulin pen needles and access to remote monitoring and bolus advise app.
Learn more here: https://www.nipro-diagnostics.co.uk/patients
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.
For more information, visit: www.novonordisk.co.uk
We have received funding by means of sponsorship from multiple pharmaceutical companies and MedTech industries to support the delivery of our national conference.
The sponsoring companies are Abbott, Lilly, Roche Diagnostics, Ascensia, Medtrum, Nipro and Novo Nordisk.
Our sponsors have had no editorial input or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.